AIMS: Uptake of continuous subcutaneous insulin infusion (CSII) by people with diabetes (PwD) in Ireland is low and exhibits regional variation. This study explores barriers and facilitators to accessing CSII by adults with Type 1 diabetes mellitus.RESEARCH DESIGN AND METHODS: A qualitative study employing focus groups with adults with Type 1 diabetes mellitus (n = 26) and semi-structured interviews with health care professionals (HCP) and other key stakeholders (n = 21) was conducted. Reflexive thematic analysis was used to analyze data, using NVivo.RESULTS: Four main themes comprising barriers to or facilitators of CSII uptake were identified. These included: (1) awareness of CSII and its benefits, (2) the structure of diabetes services, ...
Background: Self-monitoring of blood glucose (SMBG) helps to improve glycemic control and empowermen...
Background: Patients with type 2 diabetes often require insulin as the disease progresses. However...
AIMS: To determine the barriers to and enablers of engaging with specialist diabetes care and the se...
AIMS: Uptake of continuous subcutaneous insulin infusion (CSII) by people with diabetes (PwD) in Ire...
Aims The uptake of continuous subcutaneous insulin infusion (CSII) is low in adults with type 1 diab...
The overarching aim of this thesis was to explore the determinants of uptake and access to continuou...
Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type...
Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type...
Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type...
Background Type 1 diabetes is a complex chronic condition which requires lifelong treatment with ...
© 2017 John Wiley & Sons, Ltd. Rationale, aims, and objectives: Continuous subcutaneous insulin infu...
Background and Significance: Diabetes mellitus is a collection of metabolic diseases, characterized ...
OBJECTIVE: Diabetes technology is available and its efficacy and safety have been demonstrated; howe...
© 2017 John Wiley & Sons, Ltd. Rationale, aims, and objectives: Use of continuous subcutaneous insul...
RATIONALE, AIMS, AND OBJECTIVES: Continuous subcutaneous insulin infusion (CSII; insulin pump) use i...
Background: Self-monitoring of blood glucose (SMBG) helps to improve glycemic control and empowermen...
Background: Patients with type 2 diabetes often require insulin as the disease progresses. However...
AIMS: To determine the barriers to and enablers of engaging with specialist diabetes care and the se...
AIMS: Uptake of continuous subcutaneous insulin infusion (CSII) by people with diabetes (PwD) in Ire...
Aims The uptake of continuous subcutaneous insulin infusion (CSII) is low in adults with type 1 diab...
The overarching aim of this thesis was to explore the determinants of uptake and access to continuou...
Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type...
Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type...
Background: The uptake of continuous subcutaneous insulin infusion (CSII) therapy in those with type...
Background Type 1 diabetes is a complex chronic condition which requires lifelong treatment with ...
© 2017 John Wiley & Sons, Ltd. Rationale, aims, and objectives: Continuous subcutaneous insulin infu...
Background and Significance: Diabetes mellitus is a collection of metabolic diseases, characterized ...
OBJECTIVE: Diabetes technology is available and its efficacy and safety have been demonstrated; howe...
© 2017 John Wiley & Sons, Ltd. Rationale, aims, and objectives: Use of continuous subcutaneous insul...
RATIONALE, AIMS, AND OBJECTIVES: Continuous subcutaneous insulin infusion (CSII; insulin pump) use i...
Background: Self-monitoring of blood glucose (SMBG) helps to improve glycemic control and empowermen...
Background: Patients with type 2 diabetes often require insulin as the disease progresses. However...
AIMS: To determine the barriers to and enablers of engaging with specialist diabetes care and the se...